Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05980403
What this trial is testing

Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yongshun Chen 300
Not applicableWithdrawnNCT01936961
What this trial is testing

Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

Who this might be right for
Metastatic Non-Small Cell Lung CancerMetastatic Colon CancerMetastatic Triple Negative Breast Cancer
Western Regional Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07537946
What this trial is testing

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastases
Tongji Hospital 400
Testing effectiveness (Phase 2)Study completedNCT06010303
What this trial is testing

Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerEsophageal Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma by AJCC V8 Stage
BeiGene 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712094
What this trial is testing

AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Cancer
Tianjin Medical University Cancer Institute and Hospital 56
Testing effectiveness (Phase 2)Looking for participantsNCT06349980
What this trial is testing

Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 117
Testing effectiveness (Phase 2)Looking for participantsNCT07188103
What this trial is testing

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 37
Testing effectiveness (Phase 2)Study completedNCT00959647
What this trial is testing

Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Who this might be right for
Ovarian CancerBasal Cell CarcinomaMetastatic Colorectal Cancer
Genentech, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT00786643
What this trial is testing

Study of Gamma Interfereon in Metastatic Colorectal Carcinoma

Who this might be right for
Colorectal Cancer
Accelerated Community Oncology Research Network 48
Testing effectiveness (Phase 2)Looking for participantsNCT07274774
What this trial is testing

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 184
Testing effectiveness (Phase 2)Ended earlyNCT00065117
What this trial is testing

Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsMetastases, Neoplasm
AstraZeneca 180
Testing effectiveness (Phase 2)Study completedNCT01507168
What this trial is testing

GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 185
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT01658943
What this trial is testing

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more
National Cancer Institute (NCI) 137
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Study completedNCT01973725
What this trial is testing

Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yuhong Li 50
Early research (Phase 1)Looking for participantsNCT07107750
What this trial is testing

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Washington University School of Medicine 48
Early research (Phase 1)Study completedNCT01498952
What this trial is testing

MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.

Who this might be right for
Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
MedImmune LLC 6
Early research (Phase 1)Study completedNCT00441376
What this trial is testing

ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Who this might be right for
Hepatocellular CarcinomaLiver Neoplasms
Imunon 30
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Next Page